LEXICON PHARMACEUTICALS, INC. Other Nonoperating Income (Expense)
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Other Nonoperating Income (Expense) of $1.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-06
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was $1.72M, a 6.05% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was $1.54M, a 30.46% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was $1.28M, a 54.72% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was $1.57M, a 54.33% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2025 was $6.91M, a 43.80% decline from fiscal 2024.
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2024 was $12.29M, a 58.99% increase from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2023 was $7.73M, a 384.46% increase from fiscal 2022.
- LEXICON PHARMACEUTICALS, INC. other nonoperating income (expense) for fiscal 2022 was $1.60M, a 1091.04% increase from fiscal 2021.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.72M 10-Q · filed 2026-08-06 | $3.27M 10-Q · filed 2026-08-06 | $4.55M derived: sum of 3 quarters · filed 2026-08-06 | $6.12M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.54M 10-Q · filed 2026-05-07 | $2.82M derived: sum of 2 quarters · filed 2026-05-07 | $4.40M derived: sum of 3 quarters · filed 2026-05-07 | $6.23M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.85M derived: sum of 2 quarters · filed 2026-03-05 | $4.69M derived: sum of 3 quarters · filed 2026-08-06 | $6.91M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $1.57M 10-Q · filed 2025-11-06 | $3.41M derived: sum of 2 quarters · filed 2026-08-06 | $5.63M 10-Q · filed 2025-11-06 | $8.46M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $1.83M 10-Q · filed 2026-08-06 | $4.05M 10-Q · filed 2026-08-06 | $6.88M derived: sum of 3 quarters · filed 2026-08-06 | $10.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.22M 10-Q · filed 2026-05-07 | $5.05M derived: sum of 2 quarters · filed 2026-05-07 | $8.49M derived: sum of 3 quarters · filed 2026-05-07 | $12.63M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $6.27M derived: sum of 2 quarters · filed 2026-03-05 | $10.41M derived: sum of 3 quarters · filed 2026-03-05 | $12.29M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $3.44M 10-Q · filed 2025-11-06 | $7.58M derived: sum of 2 quarters · filed 2025-11-06 | $9.46M 10-Q · filed 2025-11-06 | $11.87M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | $4.14M 10-Q · filed 2025-08-06 | $6.02M 10-Q · filed 2025-08-06 | $8.42M derived: sum of 3 quarters · filed 2026-03-05 | $11.43M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | $1.88M 10-Q · filed 2025-05-14 | $4.29M derived: sum of 2 quarters · filed 2026-03-05 | $7.29M derived: sum of 3 quarters · filed 2026-03-05 | $8.59M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $5.41M derived: sum of 2 quarters · filed 2026-03-05 | $6.70M derived: sum of 3 quarters · filed 2026-03-05 | $7.73M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $3.00M 10-Q · filed 2024-11-13 | $4.30M derived: sum of 2 quarters · filed 2024-11-13 | $5.33M 10-Q · filed 2024-11-13 | $6.22M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-02 | $2.33M 10-Q · filed 2024-08-02 | $3.21M derived: sum of 3 quarters · filed 2025-03-07 | $3.78M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $1.03M 10-Q · filed 2024-05-02 | $1.92M derived: sum of 2 quarters · filed 2025-03-07 | $2.49M derived: sum of 3 quarters · filed 2025-03-07 | $2.61M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $887.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.46M derived: sum of 2 quarters · filed 2025-03-07 | $1.58M derived: sum of 3 quarters · filed 2025-03-07 | $1.60M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | $572.00K 10-Q · filed 2023-11-08 | $695.00K derived: sum of 2 quarters · filed 2023-11-08 | $709.00K 10-Q · filed 2023-11-08 | $723.00K derived: sum of 4 quarters · filed 2024-03-25 | ||||
| 2022-06-30 | $123.00K 10-Q · filed 2023-08-04 | $137.00K 10-Q · filed 2023-08-04 | $151.00K derived: sum of 3 quarters · filed 2024-03-25 | $162.00K derived: sum of 4 quarters · filed 2024-03-25 | ||||
| 2022-03-31 | $14.00K 10-Q · filed 2023-05-04 | $28.00K derived: sum of 2 quarters · filed 2024-03-25 | $39.00K derived: sum of 3 quarters · filed 2024-03-25 | $100.00K derived: sum of 4 quarters · filed 2024-03-25 | ||||
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $25.00K derived: sum of 2 quarters · filed 2024-03-25 | $86.00K derived: sum of 3 quarters · filed 2024-03-25 | $134.00K 10-K · filed 2024-03-25 | ||||
| 2021-09-30 | $11.00K 10-Q · filed 2022-11-09 | $72.00K derived: sum of 2 quarters · filed 2022-11-09 | $120.00K 10-Q · filed 2022-11-09 | $995.00K derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-06-30 | $61.00K 10-Q · filed 2022-08-03 | $109.00K 10-Q · filed 2022-08-03 | $984.00K derived: sum of 3 quarters · filed 2023-03-03 | $1.28M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2021-03-31 | $48.00K 10-Q · filed 2022-05-05 | $923.00K derived: sum of 2 quarters · filed 2023-03-03 | $1.22M derived: sum of 3 quarters · filed 2023-03-03 | $1.86M derived: sum of 4 quarters · filed 2023-03-03 | ||||
| 2020-12-31 | $875.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $1.18M derived: sum of 2 quarters · filed 2023-03-03 | $1.81M derived: sum of 3 quarters · filed 2023-03-03 | $2.77M 10-K · filed 2023-03-03 | ||||
| 2020-09-30 | $301.00K 10-Q · filed 2021-11-09 | $934.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.89M 10-Q · filed 2021-11-09 | $3.16M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-06-30 | $633.00K 10-Q · filed 2021-08-06 | $1.59M 10-Q · filed 2021-08-06 | $2.86M derived: sum of 3 quarters · filed 2022-03-10 | $3.46M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2020-03-31 | $958.00K 10-Q · filed 2021-05-06 | $2.23M derived: sum of 2 quarters · filed 2022-03-10 | $2.83M derived: sum of 3 quarters · filed 2022-03-10 | $3.52M derived: sum of 4 quarters · filed 2022-03-10 | ||||
| 2019-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $1.87M derived: sum of 2 quarters · filed 2022-03-10 | $2.56M derived: sum of 3 quarters · filed 2022-03-10 | $3.35M 10-K · filed 2022-03-10 | ||||
| 2019-09-30 | $600.00K 10-Q · filed 2020-10-30 | $1.29M derived: sum of 2 quarters · filed 2020-10-30 | $2.08M 10-Q · filed 2020-10-30 | $2.89M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-06-30 | $691.00K 10-Q · filed 2020-07-29 | $1.48M 10-Q · filed 2020-07-29 | $2.29M derived: sum of 3 quarters · filed 2021-03-12 | $3.07M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2019-03-31 | $789.00K 10-Q · filed 2020-04-27 | $1.60M derived: sum of 2 quarters · filed 2021-03-12 | $2.38M derived: sum of 3 quarters · filed 2021-03-12 | $3.29M derived: sum of 4 quarters · filed 2021-03-12 | ||||
| 2018-12-31 | $810.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $1.59M derived: sum of 2 quarters · filed 2021-03-12 | $2.50M derived: sum of 3 quarters · filed 2021-03-12 | $3.51M 10-K · filed 2021-03-12 | ||||
| 2018-09-30 | $783.00K 10-Q · filed 2019-11-07 | $1.69M derived: sum of 2 quarters · filed 2019-11-07 | $2.70M 10-Q · filed 2019-11-07 | $3.26M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-06-30 | $910.00K 10-Q · filed 2019-08-01 | $1.92M 10-Q · filed 2019-08-01 | $2.48M derived: sum of 3 quarters · filed 2020-03-12 | $2.89M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-01 | $1.57M derived: sum of 2 quarters · filed 2020-03-12 | $1.98M derived: sum of 3 quarters · filed 2020-03-12 | $2.43M derived: sum of 4 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $976.00K derived: sum of 2 quarters · filed 2020-03-12 | $1.42M derived: sum of 3 quarters · filed 2020-03-12 | $1.95M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | $415.00K 10-Q · filed 2018-11-01 | $863.00K derived: sum of 2 quarters · filed 2018-11-01 | $1.39M 10-Q · filed 2018-11-01 | $1.94M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | $448.00K 10-Q · filed 2018-07-30 | $978.00K 10-Q · filed 2018-07-30 | $1.52M derived: sum of 3 quarters · filed 2019-03-15 | $2.09M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | $530.00K 10-Q · filed 2018-05-03 | $1.07M derived: sum of 2 quarters · filed 2019-03-15 | $1.64M derived: sum of 3 quarters · filed 2019-03-15 | $2.19M derived: sum of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $1.11M derived: sum of 2 quarters · filed 2019-03-15 | $1.66M derived: sum of 3 quarters · filed 2019-03-15 | $2.29M 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | $564.00K 10-Q · filed 2017-11-08 | $1.11M derived: sum of 2 quarters · filed 2017-11-08 | $1.75M 10-Q · filed 2017-11-08 | $1.82M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $547.00K 10-Q · filed 2017-08-01 | $1.18M 10-Q · filed 2017-08-01 | $1.25M derived: sum of 3 quarters · filed 2018-03-01 | $1.33M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $637.00K 10-Q · filed 2017-05-04 | $705.00K derived: sum of 2 quarters · filed 2018-03-01 | $787.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.06M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $150.00K derived: sum of 2 quarters · filed 2018-03-01 | $419.00K derived: sum of 3 quarters · filed 2018-03-01 | $572.00K 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $82.00K 10-Q · filed 2016-11-07 | $351.00K derived: sum of 2 quarters · filed 2016-11-07 | $504.00K 10-Q · filed 2016-11-07 | $1.84M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-06-30 | $269.00K 10-Q · filed 2016-08-04 | $422.00K 10-Q · filed 2016-08-04 | $1.76M derived: sum of 3 quarters · filed 2017-03-06 | $2.04M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2015-03-31 | $153.00K 10-Q · filed 2016-05-05 | $1.49M derived: sum of 2 quarters · filed 2017-03-06 | $1.78M derived: sum of 3 quarters · filed 2017-03-06 | $2.31M derived: sum of 4 quarters · filed 2017-03-06 | ||||
| 2014-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.62M derived: sum of 2 quarters · filed 2017-03-06 | $2.16M derived: sum of 3 quarters · filed 2017-03-06 | $2.25M 10-K · filed 2017-03-06 | ||||
| 2014-09-30 | $287.00K 10-Q · filed 2015-11-09 | $282.00K 10-Q · filed 2014-11-06 | $825.00K derived: sum of 2 quarters · filed 2015-11-09 | $919.00K 10-Q · filed 2015-11-09 | $902.00K 10-Q · filed 2014-11-06 | $1.09M derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-06-30 | $538.00K 10-Q · filed 2015-08-07 | $534.00K 10-Q · filed 2014-08-07 | $632.00K 10-Q · filed 2015-08-07 | $620.00K 10-Q · filed 2014-08-07 | $807.00K derived: sum of 3 quarters · filed 2016-03-11 | $818.00K derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-03-31 | $94.00K 10-Q · filed 2015-05-05 | $86.00K 10-Q · filed 2014-05-08 | $269.00K derived: sum of 2 quarters · filed 2016-03-11 | $280.00K derived: sum of 3 quarters · filed 2016-03-11 | $276.00K derived: sum of 4 quarters · filed 2016-03-11 | |||
| 2013-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $186.00K derived: sum of 2 quarters · filed 2016-03-11 | $182.00K derived: sum of 3 quarters · filed 2016-03-11 | $216.00K 10-K · filed 2016-03-11 | $59.00K 10-K · filed 2014-03-07 | |||
| 2013-09-30 | $11.00K 10-Q · filed 2014-11-06 | $7.00K derived: sum of 2 quarters · filed 2014-11-06 | $41.00K 10-Q · filed 2014-11-06 | $338.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | -$4.00K 10-Q · filed 2014-08-07 | $30.00K 10-Q · filed 2014-08-07 | $327.00K derived: sum of 3 quarters · filed 2015-03-12 | $331.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | $34.00K 10-Q · filed 2014-05-08 | $331.00K derived: sum of 2 quarters · filed 2015-03-12 | $335.00K derived: sum of 3 quarters · filed 2015-03-12 | $356.00K derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $301.00K derived: sum of 2 quarters · filed 2015-03-12 | $322.00K derived: sum of 3 quarters · filed 2015-03-12 | $318.00K 10-K · filed 2015-03-12 | $105.00K 10-K · filed 2013-03-11 | |||
| 2012-09-30 | $4.00K 10-Q · filed 2013-11-12 | $25.00K derived: sum of 2 quarters · filed 2013-11-12 | $21.00K 10-Q · filed 2013-11-12 | $29.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-06-30 | $21.00K 10-Q · filed 2013-08-01 | $17.00K 10-Q · filed 2013-08-01 | $25.00K derived: sum of 3 quarters · filed 2014-03-07 | $113.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2012-03-31 | -$4.00K 10-Q · filed 2013-05-10 | $4.00K derived: sum of 2 quarters · filed 2014-03-07 | $92.00K derived: sum of 3 quarters · filed 2014-03-07 | $122.00K derived: sum of 4 quarters · filed 2014-03-07 | ||||
| 2011-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $96.00K derived: sum of 2 quarters · filed 2014-03-07 | $126.00K derived: sum of 3 quarters · filed 2014-03-07 | $153.00K 10-K · filed 2014-03-07 | ||||
| 2011-09-30 | $88.00K 10-Q · filed 2012-11-07 | $118.00K derived: sum of 2 quarters · filed 2012-11-07 | $145.00K 10-Q · filed 2012-11-07 | $146.00K derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-06-30 | $30.00K 10-Q · filed 2012-08-02 | $57.00K 10-Q · filed 2012-08-02 | $58.00K derived: sum of 3 quarters · filed 2013-03-11 | -$2.64M derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2011-03-31 | $27.00K 10-Q · filed 2012-05-03 | $28.00K derived: sum of 2 quarters · filed 2013-03-11 | -$2.67M derived: sum of 3 quarters · filed 2013-03-11 | -$3.31M derived: sum of 4 quarters · filed 2013-03-11 | ||||
| 2010-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-11 | -$2.70M derived: sum of 2 quarters · filed 2013-03-11 | -$3.34M derived: sum of 3 quarters · filed 2013-03-11 | -$4.02M 10-K · filed 2013-03-11 | ||||
| 2010-09-30 | -$2.70M 10-Q · filed 2011-11-01 | -$3.34M derived: sum of 2 quarters · filed 2011-11-01 | -$4.03M 10-Q · filed 2011-11-01 | |||||
| 2010-06-30 | -$643.00K 10-Q · filed 2011-08-09 | -$1.32M 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | -$2.55M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |